Finance

Lists
Why is MDMA up 2.38%?
Dive Deeper
MDMA:CNSX
Pharmala Biotech Holdings Inc
CA$ 0.22
+2.38%
(+0.0050) 1D
10-р сарын 9, 16:00:00 (GMT-4)  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MDMA...
Open
CA$ 0.21
High
CA$ 0.22
Low
CA$ 0.20
Mkt. cap
23.35 сая
Avg. vol.
170.21 мян
Volume
0.00
52-wk high
CA$ 0.33
52-wk low
CA$ 0.08
EPS
-CA$ 0.02
No. of employees
3
Open
CA$ 0.21
High
CA$ 0.22
Low
CA$ 0.20
Mkt. cap
23.35 сая
Avg. vol.
170.21 мян
Volume
0.00
52-wk high
CA$ 0.33
52-wk low
CA$ 0.08
EPS
-CA$ 0.02
No. of employees
3
News stories
From web sources and news partners
About Pharmala Biotech Holdings Inc
CEO-
Employees3
Founded2021
HeadquartersТоронто, Онтарио, Канад
Sector-
Last report
2026 оны 7-р сарын 29
Fiscal period
Q3 2026
- / -
Revenue / Est. (CAD)
513.23 мян / -
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 оны 8-р сар
2025 оны 11-р сар
2026 оны 2-р сар
2026 оны 5-р сар
Revenue
267.38 мян
206.44 мян
280.58 мян
513.23 мян
Cost of goods sold
34.04 мян
34.84 мян
22.41 мян
174.69 мян
Cost of revenue
34.04 мян
34.84 мян
22.41 мян
174.69 мян
Research and development expenses
44.91 мян
41.10 мян
40.53 мян
44.91 мян
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
404.68 мян
320.96 мян
367.29 мян
472.32 мян
Operating expense
553.47 мян
498.41 мян
559.82 мян
810.59 мян
Total operating expenses
587.50 мян
533.25 мян
582.22 мян
985.28 мян
Operating income
-320.13 мян
-326.81 мян
-301.64 мян
-472.05 мян
Other non operating income
-41.00 мян
-16.84 мян
-46.18 мян
-40.97 мян
EBT including unusual items
-361.13 мян
-409.70 мян
-337.70 мян
-499.76 мян
EBT excluding unusual items
-361.13 мян
-343.65 мян
-347.82 мян
-513.01 мян
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-361.13 мян
-409.70 мян
-337.70 мян
-499.76 мян
Net profit margin
-135.07%
-198.46%
-120.35%
-97.37%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
29.19 мян
29.76 мян
29.74 мян
30.02 мян
EBITDA
-306.98 мян
-313.10 мян
-287.95 мян
-458.08 мян
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс